Adastra Holdings Ltd. (XTXXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0378
0.00 (0.00%)
Apr 30, 2025, 4:00 PM EDT
Adastra Holdings Revenue
Adastra Holdings had revenue of 7.10M CAD in the quarter ending September 30, 2024, with 63.30% growth. This brings the company's revenue in the last twelve months to 25.11M, up 17.45% year-over-year. In the year 2023, Adastra Holdings had annual revenue of 22.22M with 67.15% growth.
Revenue (ttm)
25.11M CAD
Revenue Growth
+17.45%
P/S Ratio
0.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.34M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |